Cubist Systematic Strategies, LLC Adma Biologics, Inc. Transaction History

Cubist Systematic Strategies, LLC

$19.3 Billion
Q3 2025

A detailed history of Cubist Systematic Strategies, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 37,200 shares of ADMA stock, worth $578,832. This represents 0.0% of its overall portfolio holdings.

Number of Shares

37,200

Previous 37,400 0.53%

Holding current value

$578,832

Previous $681,000 19.97%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$15.44 - $20.61 $1.54 Million - $2.06 Million	99,721 Added 25.96%	483,797 $9.6 Million
Q4 2024 Feb 14, 2025	BUY	$15.62 - $22.62 $6 Million - $8.69 Million	384,076 New	384,076 $6.59 Million
Q2 2024 Aug 14, 2024	SELL	$5.98 - $11.18 $3.4 Million - $6.35 Million	-567,758 Reduced 55.05%	463,685 $5.18 Million
Q1 2024 May 15, 2024	BUY	$4.4 - $6.74 $3.52 Million - $5.4 Million	800,512 Added 346.65%	1,031,443 $6.81 Million
Q4 2023 Feb 14, 2024	SELL	$3.08 - $4.52 $215,085 - $315,645	-69,833 Reduced 23.22%	230,931 $1.04 Million

Q3 2023 Nov 14, 2023	SELL	$3.47 - $4.61 $91,812 - $121,975	-26,459 Reduced 8.09%	300,764 $1.08 Million
Q2 2023 Aug 14, 2023	BUY	$3.12 - $4.22 $581,692 - $786,776	186,440 Added 132.43%	327,223 $1.21 Million
Q1 2023 May 15, 2023	BUY	$3.01 - $3.87 $56,142 - $72,183	18,652 Added 15.27%	140,783 $465,000
Q4 2022 Feb 14, 2023	BUY	$2.47 - $3.88 $301,663 - $473,868	122,131 New	122,131 $473,000
Q2 2022 Aug 15, 2022	SELL	$1.43 - $2.2 $454,085 - $698,592	-317,542 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.28 - $1.83 $166,069 - $237,427	129,742 Added 69.09%	317,542 $581,000
Q4 2021 Feb 14, 2022	BUY	$1.09 - $1.66 $204,702 - $311,748	187,800 New	187,800 $265,000
Q3 2021 Nov 15, 2021	SELL	$1.13 - $1.65 $70,606 - $103,098	-62,484 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.51 - $2.07 $28,967 - $39,710	19,184 Added 44.3%	62,484 $100,000
Q1 2021 May 17, 2021	BUY	$1.67 - $2.95 $72,311 - $127,735	43,300 New	43,300 $76,000
Q2 2020 Aug 14, 2020	SELL	$2.42 - $3.29 $14,752 - $20,055	-6,096 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.5 - $4.59 $9,144 - $27,980	6,096 New	6,096 $18,000

Others Institutions Holding ADMA

# of Institutions

402

Shares Held

204M

Call Options Held

3.06M

Put Options Held

1.88M

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.06B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Adma Biologics, Inc. Transaction History